EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population

Sue Kwon iD, Stefan Sillau, John R Corboy iD, Kavita V Nair, Aaron M Carlson iD

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52069 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Sue Kwon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Multiple Sclerosis Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our objectives were to (1) obtain the prevalence and demography of people with multiple sclerosis (MS) in a representative Colorado population, and (2) to assess the utilization of disease‐modifying therapy within this prevalent cohort.

Methods

This is a retrospective, observational study of patients that had contact with the University of Colorado Health System from 2012 to 2020. We queried Health Data Compass, a data warehouse, for patient data and applied the MS Prevalence Workgroup Algorithm to generate a prevalent cohort. We calculated prevalence as of 31 December 2020, and stratified by age, sex, race, and ethnicity. Payer information and treatment exposure were obtained from linked claims from the Colorado All Payers Claim Database. Disease‐modifying therapies were classified as highly effective and moderately effective based on the clinical trial, TREAT‐MS (NCT03500328).

Results

From a population of 1,382,821 individuals, 8557 people with MS were captured. Age‐adjusted prevalence of MS as of 31 December 2020 was 572.3 per 100,000 with a mean age of 47.36. Prevalence varied between demographic subgroups, with the lowest prevalence in Hispanic men (215.6) and highest in White (824.1) and Black women (820.1). Overall disease‐modifying therapy exposure was 62.4%, with increased highly effective therapy use and a corresponding decrease in moderately effective therapy use on a yearly basis.

Interpretation

MS is highly prevalent in a representative Colorado cohort. Overall treatment and proportion of highly effective therapy exposure increased significantly during a critical period of MS therapeutic advances, indicating a shift in disease management driven sharply by the availability of on‐label anti‐CD20 therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansMaleFemaleAdultMiddle AgedPrevalenceRetrospective StudiesColoradoYoung AdultAgedAdolescentUnited States

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Sue Kwon, John R Corboy, Aaron M Carlson

Förderung

  • National Multiple Sclerosis Society

Zitieren

APA

Kwon, S., Sillau, S., Corboy, J. R., Nair, K. V., & Carlson, A. M. (2024). Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52069

Vancouver

Kwon S, Sillau S, Corboy JR, Nair KV, Carlson AM. Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52069

BibTeX
@article{Kwon2024,
  author = {Kwon, Sue and Sillau, Stefan and Corboy, John R and Nair, Kavita V and Carlson, Aaron M},
  title = {Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52069}
}
Kostenlos starten →